ULURU Inc. Announces Poster Presentations at the 23rd Annual 'Clinical Symposium on Advances in Skin & W...( ADDISON Texas Oct. 28 /- ULURU In...),Health
Navigation Links
ULURU Inc. Announces Poster Presentations at the 23rd Annual 'Clinical Symposium on Advances in Skin & Wound Care'
Date:10/28/2008
ADDISON, Texas, Oct. 28 /PRNewswire-FirstCall/ -- ULURU Inc. (Amex: ULU) today announced that it will present two posters at the "Clinical Symposium on Advances in Skin and Wound Care" being held in Las Vegas from October 27 to October 30, 2008.
The principal author on the poster titled, "Altrazeal(TM), A Transforming Powder Wound Dressing: The Clinical Experience" (poster #153) is Dr. Jeffrey A. Niezgoda, M.D., FACHM, FAPWCA, Director of the Centers for Comprehensive Wound Care and Hyperbaric Oxygen Therapy, Aurora Health Care. Several case studies are presented to illustrate the dynamic clinical benefits of this novel technology. The early clinical experience demonstrates excellent patient toleration and improved wound healing. Additional benefits include ease of application and a reduction in dressing changes with or without a secondary dressing.
The second poster (poster #154) is titled "The Design and Performance of Nanoflex(TM) Transforming Powder Dressing: A Novel Wound Care Management System". John V. St. John, Ph.D., Vice President of Material Science at ULURU Inc. and a co-inventor of this proprietary technology is the principal author of this poster which describes the physical properties of the dressing, pre-clinical data and a patient case study. The design features of Altrazeal(TM), which are unique to this material, including the high moisture vapor transpiration rate, fluid uptake and material strength are presented on this poster.
Altrazeal(TM), a transforming powder dressing, which is produced using
our Nanoflex(TM) Technology, is a breakthrough new treatment for exuding
wounds including burns, trauma, skin graft donor sites, surgical wounds and
chronic slow-healing wounds such as diabetic foot ulcers, pressure ulcers
and venous ulcers. Altrazeal(TM) is designed to provide greater
effectiveness in wound closure by promoting an optimal moist wound healing
environment. Altrazeal(TM) provides additional patient benefits inc
'/>"/>
| SOURCE ULURU Inc. Copyright©2008 PR Newswire. All rights reserved |
Related medicine news :
1. ULURU Inc. to Present at UBS Global Life Sciences Conference 2007
2. ULURU Inc. Announces Odd-Lot Buy Back Offer
3. ULURU Inc. Announces Conference Call to Discuss Financial Results for the Third Quarter Ended September 30, 2007 and Provide a Business Update
4. ULURU Inc. Reports Third Quarter 2007 Results
5. ULURU Inc. Announces Issuance of Notice of Allowance for Nanoparticle Aggregate Patent
6. ULURU Inc. to Present at Cowen and Company 28th Annual Health Care Conference 2008
7. ULURU Inc. Announces Conference Call to Discuss Financial Results for the First Quarter Ended March 31, 2008 and Provide a Business Update
8. ULURU Inc. Announces Conference Call to Discuss Financial Results for the Fourth Quarter Ended December 31, 2007 and Provide a Business Update
9. ULURU Inc. Announces the Launch Plan for Altrazeal(TM)
10. ULURU Inc. Reports First Quarter 2008 Financial Results
11. ULURU Inc. Announces the Appointment of Ronald A. Ahrens to the Board of Directors
Post Your Comments:
(Date:12/1/2009)..., , WASHINGTON, Dec. 1 /PRNewswire-US...06 state prisoners and 1,538 federal prisoners wer...f Justice Statistics (BJS) in the Office of Justic...today. At yearend 2008, an estimated 5,672 inmates...down from 5,762 in 2007. In 2007, about 43 per 10,...
(Date:12/1/2009)...Could identify those who would benefit from liver ...UESDAY, Dec. 1 (HealthDay News) -- A CT scan of li...er may help predict overall survival after chemoth... (Avastin) to cytotoxic chemotherapy has been show...colorectal cancer and to produce better results in...
(Date:12/1/2009)... Practitioners of any med...anscription are breathing a sigh of relief this we...iPhone. The application, released over the holida...ranscribe voice recordings to do so quickly and se... (PRWEB) December 1, 2009 -- The...
(Date:12/1/2009)..., , ,, NEW YORK, Dec. 1 /... and a global leader in the development and delive... for the medical, scientific and academic markets,...iversal Search, our first-to-market cross-platform...psychology lexicon, based on the American Psycholo...
(Date:12/1/2009)..., , FORT LAUDERDALE, Fla., Dec. 1 /PRNew...n of patient enrollment in the randomized clinical...ng Stent (Combo Stent). ,, A prospective, rando... E valuation of an ablu M inal sirolimus coat ...0 patients at up to 20 sites in Asia, Australia, E...
Breaking Medicine News(10 mins):Health News:Rate of Confirmed AIDS in Prison 2.5 Times the Rate in the U.S. General Population 2Health News:Rate of Confirmed AIDS in Prison 2.5 Times the Rate in the U.S. General Population 3Health News:CT Scan May Predict Colon Cancer Survival 2Health News:Medical and Legal Professionals Find Relief Leveraging Apple iPhone App for Dictation and Transcription 'On the Go' 2Health News:Ovid Highlights the Latest Productivity Workflow Enhancements to Ovid Universal Search(TM) and its New Psychology Lexicon at London's Online Information 2009 Conference 2Health News:Ovid Highlights the Latest Productivity Workflow Enhancements to Ovid Universal Search(TM) and its New Psychology Lexicon at London's Online Information 2009 Conference 3Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 2Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 3Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 4[0] Rate of Confirmed AIDS in Prison 2.5 Times the Rate in the U.S. General Population[0] CT Scan May Predict Colon Cancer Survival [0] Medical and Legal Professionals Find Relief Leveraging Apple iPhone App for Dictation and Transcription 'On the Go'[0] Ovid Highlights the Latest Productivity Workflow Enhancements to Ovid Universal Search(TM) and its New Psychology Lexicon at London's Online Information 2009 Conference[0] OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent
...h HIV/AIDS Advocacy Group Act up-Paris has landed ...it against them for a cyber attack on their web si...
Act Up-Paris on April 26 organized an attac...Kaletra in Thailand.
Pharmaceutical company...
...hase Cancer Center researchers say that they have ...T cells protect the body from viral diseases. Publ...the National Academy of Science, their study shows...invading virus occurs.
Lead author of the ...
...ts have always suspected it, and now a scientific ...exual activity and drugs do make teens feel older ...y of Alberta in Edmonton, Canada, along with resea...etween 12 to 19 years of age from a medium-sized N...
...vananthapuram, Members of the Congress-led opposit...s in the assembly even after it was adjourned - to...6 people.
"We are prepared to sit through ...rmer chief minister Oommen Chandy, now leader of t...
...rch from The University of Arizona Sarver Heart Ce... the risk for heart disease. Excessive body weig...scle in the left ventricle, the hearts pumping cha...rved that the thickening in the muscle wall become...
...news at hand for psychiatrists. And for patients t...ecially, might not be too very excited . Doctors m...ti-depressant to another hereafter. With a simple ...after it should be relatively easy to figure out w...
Other Medicine News:Health News:Abbot Sues French AIDS Group 2Health News:Body's Defence Mechanism Against Viral Disease Discovered 2Health News:Dating, Drugs and Sex Make Teens Feel Older Than They are 2Health News:Kerala Opposition's Unique Protest Over Fever Deaths 2Health News:Genetic Tests Could Help Decide the Right Anti-depressants 2Health News:Genetic Tests Could Help Decide the Right Anti-depressants 3(Date:12/1/2009)..., , ARLINGTON, Va., Dec. 1 /PRNewswir... its newest report, The Market Outlook for Resea...appropriated to the NIH Scientific Research progra...RRA) is being earmarked for lab renovations, Chall...d research that spans multiple public and non-prof...
(Date:12/1/2009)..., , ATLANTA, Dec. 1 /PRNewswire-FirstCal...ogical medical device and cardiovascular tissue pr...guidance for 2010. ,, The Company expects total...$118.0 million and $123.0 million, which includes ...unding received from the Department of Defense in ...
(Date:12/1/2009)..., , CHICAGO, Dec. 1 A...ociety of North America (RSNA), Royal Philips Elec...al Breast Workspace, a set of solutions that provi...ity breast images at one workspot to help drive qu...o breast care, Philips will also highlight new cap...
Breaking Medicine Technology:BioInformatics, LLC New Report - The Market Outlook for Research Products in FY2010 2BioInformatics, LLC New Report - The Market Outlook for Research Products in FY2010 3CryoLife Provides Initial 2010 Financial Guidance 2CryoLife Provides Initial 2010 Financial Guidance 3CryoLife Provides Initial 2010 Financial Guidance 4CryoLife Provides Initial 2010 Financial Guidance 5Philips Introduces Multi-Modality Breast Workspace to Complement Comprehensive Portfolio of Diagnostic Imaging Solutions for Breast Care 2Philips Introduces Multi-Modality Breast Workspace to Complement Comprehensive Portfolio of Diagnostic Imaging Solutions for Breast Care 3Philips Introduces Multi-Modality Breast Workspace to Complement Comprehensive Portfolio of Diagnostic Imaging Solutions for Breast Care 4Suicide Risk With Antidepressants Falls With Age 54272 1Suicide Risk With Antidepressants Falls With Age 54272 2Suicide Risk With Antidepressants Falls With Age 54272 3Caraco Pharmaceutical Laboratories Ltd Markets Generic Imitrex 28R 29 Tablets 54270 1Caraco Pharmaceutical Laboratories Ltd Markets Generic Imitrex 28R 29 Tablets 54270 2HearUSA Makes Hearing Aids and Care Available to AARP Members 54269 1HearUSA Makes Hearing Aids and Care Available to AARP Members 54269 2HearUSA Makes Hearing Aids and Care Available to AARP Members 54269 3HearUSA Makes Hearing Aids and Care Available to AARP Members 54269 4...announced today at the American Diabetes Associati...ulin detemir [rDNA origin] injection) can,be used ...onse to insulin,glargine over a 24-hour period in ...rces that once-daily Levemir has a similar 24-hour...essor Allen B. King,Diabetes Care Center, Salinas,...
...ific Sessions, SAN FRANCISCO, June 7 Sanofi-aven...inding study for its new,injectable diabetes compo...e American Diabetes Association,s (ADA) 68th Annua...lifornia., The study found that AVE0010 was well ...rol versus placebo in type 2 diabetes patients,ina...
Other Medicine Technology:New Data From Head-to-Head Study Confirms Once-Daily Levemir(R) is as Effective as Glargine over a 24-Hour Period in Subjects with Type 2 Diabetes 2New Data From Head-to-Head Study Confirms Once-Daily Levemir(R) is as Effective as Glargine over a 24-Hour Period in Subjects with Type 2 Diabetes 3New Data From Head-to-Head Study Confirms Once-Daily Levemir(R) is as Effective as Glargine over a 24-Hour Period in Subjects with Type 2 Diabetes 4New Diabetes Compound AVE0010 Showed Clear Dose Response Results With Once-A-Day Injection in Phase IIb Study 2New Diabetes Compound AVE0010 Showed Clear Dose Response Results With Once-A-Day Injection in Phase IIb Study 3New Diabetes Compound AVE0010 Showed Clear Dose Response Results With Once-A-Day Injection in Phase IIb Study 4| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |